PMI’s SynCardia STAH is FDA/Health Canada approved and clinically validated. However, its revenues remain modest. This limited adoption tapers my optimism on an otherwise revolutionary piece of ...
Picard Medical (PMI), the developer of the SynCardia artificial heart, disclosed this week its plans to seek a public listing on the New York Stock Exchange under the ticker symbol PMI to raise as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results